Mass Tort brief
Medical Device and Pharma Bellwethers Test MDL Settlement Baselines
A landmark $40M catheter award and a key infant formula defense verdict establish competing valuation boundaries across multi-thousand-case dockets.
Mass Tort
Mead Johnson won the first federal baby formula bellwether — delivering a critical defense victory that blunts settlement pressure across 800 pending claims.
BackgroundNecrotizing enterocolitis is a severe, often fatal bowel inflammation that damages intestinal tissue in vulnerable premature infants. Parents filed hundreds of product liability lawsuits alleging formula makers failed to warn that cow's-milk formulations carry higher risks than human breast milk.
- The jury in Inman v. Mead Johnson rejected design defect and failure-to-warn claims, determining hospital neonatologists made appropriate medical feeding choices.
- The verdict marks the first federal bellwether decision before Senior U.S. District Judge Rebecca Pallmeyer, setting an early defense benchmark.
- The win counterbalances prior multi-million-dollar state court verdicts in Illinois and Missouri, giving Reckitt Benckiser breathing room in settlement talks.
Mass Tort
Bayer's $7.25B Roundup class settlement is facing bitter courtroom pushback — with trial lawyers fighting to prevent a 21-year liability shield for glyphosate.
BackgroundBayer inherited tens of thousands of cancer lawsuits after acquiring Monsanto in 2018, with plaintiffs alleging glyphosate exposure caused their non-Hodgkin lymphoma. The German conglomerate has pursued nationwide class deals alongside appeals to the U.S. Supreme Court over federal pesticide labeling preemption.
- The settlement plan disperses capped payments between $10,000 and $165,000 over 21 years to resolve both active and future cancer diagnoses.
- Fourteen plaintiff law firms filed formal objections, arguing the 21-year structure protects Bayer while providing inadequate compensation for terminal conditions.
- The St. Louis judge took final approval under advisement, while Bayer separately petitions the Supreme Court on federal pesticide preemption defenses.
Mass Tort
A $40M federal verdict established clear liability for Bard PowerPort fractures — putting immediate settlement pressure on Becton Dickinson across 3,700 pending lawsuits.
BackgroundBard PowerPorts are surgically implanted vascular devices designed to deliver chemotherapy and intravenous medications directly into major veins. The multidistrict litigation alleges that defective polyurethane formulations cause the catheter tubing to degrade, crack, and break off inside patients' circulatory systems.
- The Phoenix jury held C.R. Bard and parent firm Becton, Dickinson liable for design defects and failure to warn doctors about catheter degradation risks.
- The plaintiff underwent emergency open-chest heart surgery to retrieve migrated plastic fragments after suffering life-threatening cardiac arrhythmias during routine treatment.
- The substantial single-plaintiff award provides strong valuation leverage for plaintiffs ahead of the next scheduled federal bellwether trial in October.
Mass Tort
America's largest corporations are pushing federal judges to unmask private equity funders in mass torts — seeking to dismantle secret financing behind mass injury suits.
BackgroundCommercial litigation finance allows outside hedge funds and private equity firms to bankroll lawsuits in exchange for a slice of final settlements or verdicts. Corporate defendants argue that secret financial backers prolong legal disputes and block reasonable early settlements to maximize fund returns.
- The petition to the Committee on Rules of Practice and Procedure requests amendments to the Federal Rules of Civil Procedure requiring automatic disclosure.
- Corporate signatories argue that undisclosed private financiers frequently hold contractual veto power over settlement negotiations and trial calendar strategies.
- Several federal MDL judges have already instituted local standing orders requiring disclosure to evaluate potential judicial conflicts and real parties in interest.
Mass Tort
Unlock the full brief
Sign in to read every signal, takeaway, and source. Free account — Apple, Google, or email.
